Deferasirox effectively reduces iron overload in non-transfusion-dependent thalassemia (NTDT) patients: 1-year extension results from the THALASSA study

Patients with non-transfusion-dependent thalassemia (NTDT) often develop iron overload that requires chelation to levels below the threshold associated with complications. This can take several years in patients with high iron burden, highlighting the value of long-term chelation data. Here, we repo...

Descripción completa

Detalles Bibliográficos
Autores principales: Taher, Ali T., Porter, John B., Viprakasit, Vip, Kattamis, Antonis, Chuncharunee, Suporn, Sutcharitchan, Pranee, Siritanaratkul, Noppadol, Galanello, Renzo, Karakas, Zeynep, Lawniczek, Tomasz, Habr, Dany, Ros, Jacqueline, Zhu, Zewen, Cappellini, M. Domenica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3790249/
https://www.ncbi.nlm.nih.gov/pubmed/23775581
http://dx.doi.org/10.1007/s00277-013-1808-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3790249/
https://www.ncbi.nlm.nih.gov/pubmed/23775581
http://dx.doi.org/10.1007/s00277-013-1808-z

Ejemplares similares